Home Newsfeeds Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf

byBenzinga Newsdesk

November 30, 2022

1 minute read

https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_11302022_IMNN_Bautz.pdf

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation

By Vandana Singh

February 14, 2:25 PM

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

CAH

Global
News

Wearable Devices Expands In North America, Bringing AI-Powered Wearables To Silicon Valley

By Benzinga Newsdesk

December 7, 9:21 AM

engagementYOKNEAM ILLIT, ISRAEL, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the "Company" or "Wearable Devices") (NASDAQ:WLDS, WLDSW)))), a technology growth company specializing in artificial intelligence

WLDS

NextCure Presents Initial Data From Clinical Trial Of NC762 And A Trial In Progress Poster For NC410 Combo At The 2022 Society For Immunotherapy Of Cancer Annual Meeting

By Benzinga Newsdesk

November 7, 9:12 AM

NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today

NXTC

U.S. Stocks Open Higher; Deere Posts Upbeat Q2 Results

By Lisa Levin

May 19, 9:58 AM

U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.17% to 33,594.20 while the NASDAQ rose 0.28% to 12,724.56. The S&P 500, also rose, gaining, 0.34% to 4,212.26.

CWD

Watching Imunon, Zacks Small-Cap Research Sets $17 Price Valuation

Related Posts

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation

Wearable Devices Expands In North America, Bringing AI-Powered Wearables To Silicon Valley

NextCure Presents Initial Data From Clinical Trial Of NC762 And A Trial In Progress Poster For NC410 Combo At The 2022 Society For Immunotherapy Of Cancer Annual Meeting

U.S. Stocks Open Higher; Deere Posts Upbeat Q2 Results